Answers are grounded in this paper and cite their sources.
Objective To assess the sex difference in the prevalence of COVID-19 confirmed cases. Design Systematic review and meta-analysis. Setting PubMed, Cochrane Library and Google Scholar were searched for related information. The authors developed a data extraction form on an Excel sheet and the following data from eligible studies were extracted: author, country, sample size, number of female patients and number of male patients. Using STATA V.14 for analysis, the authors pooled the overall prevalence of men and/or women using a random-effect meta-analysis model. The authors examined the heterogeneity in effect size using Q statistics and I 2 statistics. Subgroup and sensitivity analyses were performed. Publication bias was also checked. Participants Studies on COVID-19 confirmed cases were included. Intervention Sex (male/female) of COVID-19 confirmed cases was considered. Primary and secondary outcome measures The primary outcome was prevalence of COVID-19 among men and women. Results A total of 57 studies with 221 195 participants were used in the analysis. The pooled prevalence of COVID-19 among men was found to be 55.00 (51.43–56.58, I 2 =99.5%, p<0.001). Sensitivity analysis showed the findings were not dependent on a single study. Moreover, a funnel plot showed symmetrical distribution. Egger’s regression test p value was not significant, which indicates absence of publication bias in both outcomes. Conclusions The prevalence of symptomatic COVID-19 was found to be higher in men than in women. The high prevalence of smoking and alcohol consumption contributed to the high prevalence of COVID-19 among men. Additional studies on the discrepancies in severity and mortality rate due to COVID-19 among men and women and the associated factors are recommended.
No takes yet. Share an insight, caveat, or question.
Abate et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: